This is a malignant disease of the prostate, in which prostate cells become cancerous. It has a high incidence in developed or highly developed countries and accounts for 15% of all cancers diagnosed.

Risk factors

Hereditary and family factors play a role in its causes. Hereditary cases are rare, and it has been proven that African Americans have a higher incidence.

Risk factors related to prostate cancer include the consumption of fats, proteins, meat, and alcohol.

Genetic studies

Our protocols include genetic studies based on blood samples to increase the accuracy of which patients really need a prostate biopsy and, based on the tissue obtained from the prostate biopsy, this will give us information about the aggressiveness of the cancer and we will be able to choose the most appropriate treatment for our patient more accurately.

Once prostate cancer has been diagnosed, it is necessary to complete the examination with a staging study. To do this, we offer the best imaging techniques such as bone scintigraphy, PET-CT (choline, PSMA) or MRI, depending on the indication.

Advanced and metastatic prostate cancer

If the tumour is advanced and has metastasised, urologists, in conjunction with multidisciplinary teams, can now initiate systemic treatments that have been shown to significantly improve survival rates.

Follow-up

After treatment, strict follow-up is required for several years. You will receive psychological support from our team of psychologists for cancer patients, so that you can return to normal as quickly as possible.

SintomasSintomasSYMPTOMS

The symptoms of prostate cancer are associated with urination problems such as decreased urine flow, increased frequency of urination, post-void dribbling, or the feeling of incomplete emptying after urination, although these symptoms do not usually appear until the disease is advanced, which is why early diagnosis is important.

DiagnosticoDiagnosticoDIAGNOSIS

Prostate cancer screening is recommended from the age of 50, or from 45 if there is a family history of the disease. Screening for patients meeting these criteria will include:

  • A physical examination
  • A blood test for PSA (prostate-specific antigen) and a urine test.

If prostate cancer is highly suspected after this initial screening, a prostate biopsy will be necessary. At our centre, we offer fusion biopsy, which combines the precision of magnetic resonance imaging and transrectal ultrasound and offers the best guarantees for detecting a higher percentage of significant cancers, which are those that will truly benefit from treatment.

TratamientoTratamientoTREATMENT

Fortunately, there are now many options for treating prostate cancer. Our department offers our patients the following treatments:

  • Observation
  • Active surveillance
  • Radical surgery
  • External radiotherapy
  • Brachytherapy
  • Focal therapy
  • Prostate ablation
  • Hormone therapy

We will adapt to your needs by offering you the technique that provides the best results based on morbidity, survival rate, patient life expectancy, tumour grade and patient preferences.

Patients are grouped into three risk categories:

  • Low risk: PSA < 10 ng/mL and GS < 7 (ISUP grade 1) and cT1-2a. Localised
  • Intermediate risk: PSA 10-20 ng/mL or GS 7 (ISUP grade 2/3) or cT2b. Localised
  • High risk:
    • PSA > 20 ng/mL or GS > 7 (ISUP grade 4/5) or cT2b. Localised
    • any PSA any GS cT3-4 or cN+ any ISUP grade. Locally advanced
Specialties:
  • Oncology
  • Urology